Literature DB >> 25616525

Strategies for the production of difficult-to-express full-length eukaryotic proteins using microbial cell factories: production of human alpha-galactosidase A.

Ugutz Unzueta1, Felicitas Vázquez, Giulia Accardi, Rosa Mendoza, Verónica Toledo-Rubio, Maria Giuliani, Filomena Sannino, Ermenegilda Parrilli, Ibane Abasolo, Simo Schwartz, Maria L Tutino, Antonio Villaverde, José L Corchero, Neus Ferrer-Miralles.   

Abstract

Obtaining high levels of pure proteins remains the main bottleneck of many scientific and biotechnological studies. Among all the available recombinant expression systems, Escherichia coli facilitates gene expression by its relative simplicity, inexpensive and fast cultivation, well-known genetics and the large number of tools available for its biotechnological application. However, recombinant expression in E. coli is not always a straightforward procedure and major obstacles are encountered when producing many eukaryotic proteins and especially membrane proteins, linked to missing posttranslational modifications, proteolysis and aggregation. In this context, many conventional and unconventional eukaryotic hosts are under exploration and development, but in some cases linked to complex culture media or processes. In this context, alternative bacterial systems able to overcome some of the limitations posed by E. coli keeping the simplicity of prokaryotic manipulation are currently emerging as convenient hosts for protein production. We have comparatively produced a "difficult-to-express" human protein, the lysosomal enzyme alpha-galactosidase A (hGLA) in E. coli and in the psychrophilic bacterium Pseudoalteromonas haloplanktis TAC125 cells (P. haloplanktis TAC125). While in E. coli the production of active hGLA was unreachable due to proteolytic instability and/or protein misfolding, the expression of hGLA gene in P. haloplanktis TAC125 allows obtaining active enzyme. These results are discussed in the context of emerging bacterial systems for protein production that represent appealing alternatives to the regular use of E. coli and also of more complex eukaryotic systems.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25616525     DOI: 10.1007/s00253-014-6328-9

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  8 in total

Review 1.  Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives.

Authors:  Melani Solomon; Silvia Muro
Journal:  Adv Drug Deliv Rev       Date:  2017-05-11       Impact factor: 15.470

2.  Recombinant Protein Production and Purification of Insoluble Proteins.

Authors:  Neus Ferrer-Miralles; Paolo Saccardo; José Luis Corchero; Elena Garcia-Fruitós
Journal:  Methods Mol Biol       Date:  2022

3.  Soluble Recombinant Protein Production in Pseudoalteromonas haloplanktis TAC125: The Case Study of the Full-Length Human CDKL5 Protein.

Authors:  Marzia Calvanese; Andrea Colarusso; Concetta Lauro; Ermenegilda Parrilli; Maria Luisa Tutino
Journal:  Methods Mol Biol       Date:  2022

Review 4.  Factors Affecting the Expression of Recombinant Protein and Improvement Strategies in Chinese Hamster Ovary Cells.

Authors:  Zheng-Mei Li; Zhen-Lin Fan; Xiao-Yin Wang; Tian-Yun Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-07-04

5.  The pangenome of (Antarctic) Pseudoalteromonas bacteria: evolutionary and functional insights.

Authors:  Emanuele Bosi; Marco Fondi; Valerio Orlandini; Elena Perrin; Isabel Maida; Donatella de Pascale; Maria Luisa Tutino; Ermenegilda Parrilli; Angelina Lo Giudice; Alain Filloux; Renato Fani
Journal:  BMC Genomics       Date:  2017-01-17       Impact factor: 3.969

6.  Active human full-length CDKL5 produced in the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125.

Authors:  Andrea Colarusso; Concetta Lauro; Marzia Calvanese; Ermenegilda Parrilli; Maria Luisa Tutino
Journal:  Microb Cell Fact       Date:  2022-10-14       Impact factor: 6.352

7.  Improving the Secretory Expression of an -Galactosidase from Aspergillus niger in Pichia pastoris.

Authors:  Xianliang Zheng; Bo Fang; Dongfei Han; Wenxia Yang; Feifei Qi; Hui Chen; Shengying Li
Journal:  PLoS One       Date:  2016-08-22       Impact factor: 3.240

8.  New insights on Pseudoalteromonas haloplanktis TAC125 genome organization and benchmarks of genome assembly applications using next and third generation sequencing technologies.

Authors:  Weihong Qi; Andrea Colarusso; Miriam Olombrada; Ermenegilda Parrilli; Andrea Patrignani; Maria Luisa Tutino; Macarena Toll-Riera
Journal:  Sci Rep       Date:  2019-11-11       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.